Cancer

News

NICE rejects Astellas' Xospata in AML, queries MSD's Keytrud...

NICE has been busy with announcements today, rejecting Astellas’ Xospata for a certain type of acute myeloid leukaemia (AML) and querying evidence for MSD's Keytruda in head and neck cancer

News

GSK's CEO Walmsley aiming for six new approvals in 2020

GlaxoSmithKline’s CEO Emma Walmsley has said the company hopes to get at least six new drug approvals in the next year.

News

Astellas to work with Adaptimmune to develop 'off the shelf'...

Astellas is to work with UK biotech Adaptimmune Therapeutics to develop allogeneic ‘off-the-shelf’ T-cell therapies for cancer.

Partner Content

Partner Content

Life with multiple myeloma

Multiple myeloma patient Bob Munro (pictured below) explains what it's like to live with the rare blood cancer and how his diagnosis led him on the journey of a lifetime – cycling from

News

Experts call for review of innovative cancer therapies to bo...

There should be an independent review of how advances in cancer treatment are valued and paid for by the NHS and healthcare providers, according to a new policy report calling for improveme

News